Evidence map›Paper›PMID 36301454›Full record

ReviewChinese journal of integrative medicine2023

Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future.

Xue-Yuan Yang, Wan-Ling Cai, Chen-Lu Guo, Qi-Hua Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Chinese journal of integrative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xue-Yuan YangDepartment of Andrology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Wan-Ling CaiDepartment of Dermatology, Shuguang Hospital, Shanghai University of Chinese Medicine, Shanghai, 201203, China.
Chen-Lu GuoDepartment of Andrology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Qi-Hua ChenDepartment of Andrology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China. 1105165868@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic skin disease and an important health concern. Western medicine and therapies are the main treatment strategies for psoriasis vulgaris (PV); however, the overall prognosis of patients with PV is still poor. Therefore, PV prevention is especially crucial. Chinese medicine (CM) has a long history of treating psoriasis, and it has unique wisdom in different cognitive angles and treatment modes from modern medicine. In this review, we first summarized the herbs and ancient CM formulas that have therapeutic effects on PV. Second, the research status and obstacles to the current development of CM in modern medicine were reviewed. Finally, the future of CM in the context of precision medicine and integrated medicine was discussed. After a detailed reading of the abundant literature, we believe that CM, through thousands of years of continuous development and clinical practice, has achieved high effectiveness and safety for PV treatment, despite its surrounding controversy. Moreover, precise analyses and systematic research methods have provided new approaches for the modernization of CM in the future. The treatment of PV with CM is worth popularizing, and we hope it can benefit more patients.

Indexed as

Drugs, Chinese HerbalPsoriasisDrug Therapy, CombinationHumansMedicine, Chinese TraditionalResearch DesignDrugs, Chinese HerbalChinese herbal medicineChinese medicinemolecular mechanismnetwork pharmacologypsoriasis vulgaris

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.